Hemptown USA Closes CAD$23 Million Capital Raise

The company is now positioned for rapid multi-state expansion and full vertical integration within the global hemp industry.

Subscribe

CENTRAL POINT, Ore., May 14, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- PRESS RELEASE -- Hemptown Organics Corp., a multi-state hemp operation doing business as Hemptown USA, has announced the completion of a CAD$23,240,000 round of financing, which closed May 10, 2019. Canaccord Genuity Corp. acted as lead agent on the brokered portion of the financing on behalf of a syndicate of dealers that included Sprott Capital Partners LP, Beacon Securities Ltd. and PI Financial Corp. In concert with existing revenue and capital, the financing enables Hemptown USA to embark on a multi-state expansion; purchase USD$5.5 million worth of Oregon CBD (cannabidiol) seeds; begin the build-out of Hemptown USA's processing and extraction facilities and research team, and initiate planting and harvesting of Hemptown USA's 2019 crop of feminized hemp seeds.

With this capital infusion, Hemptown USA is endeavouring to become a formidable multi-state operation within the rapidly growing hemp industry. As a byproduct of growing high-grade feminized hemp, Hemptown USA is proposing to processes full spectrum CBD and CBG crude and distillates, achieving higher yields versus industrial hemp. Hemptown USA’s competitive advantages include, but are not limited to:

  • A first-year yield of 110,000 lbs of feminized hemp biomass.
  • A projected gross margin greater than 77 percent on average from 2018’s harvest.
  • Is one of the largest CBG producers in the United States with Hemptown USA's purchase of 1 million rare CBG seeds for the 2019 growing season. 
  • Producing some of the world’s most coveted strain profiles containing 15 to 20 percent full spectrum CBD, CBG and other cannabinoids and terpenes.
  • Presently growing 1,500 acres in Oregon, Kentucky and Colorado with the capability to more than double the acreage in 2020 and each year after.
  • An R&D plan designed to allow Hemptown USA to farm more novel cannabinoid strains in large quantities (CBC, CBDV and CBGV) in 2020, 2021 and 2022.
  • Plans  to acquire a GMP- certified nutraceutical facility to develop unique cannabinoid products for the health and wellness industry .
  • Plans to enter into the consumer packaged goods sector by building and acquiring high-potential brands.

“Successful companies in this sector will be those with the ability to build a scalable, vertically integrated multi-state company,” stated Rod Wolterman, founder and chairman of Hemptown USA. “We have assembled a well-respected team that has already produced some of the highest quality feminized hemp in the country here in Southern Oregon’s Emerald Triangle. The capital infusion will allow us to expand operations to Colorado, Kentucky and Northern California, ramp up processing capabilities, and develop disruptive product formulations in the CPG sector. We are excited to execute on our vision and delivering sustainably grown feminized hemp flower and biomass on a commercial scale."